Magnesium and Restrictive pulmonary disease - a phase IV clinical study of FDA data

Summary:

Restrictive pulmonary disease is reported as a side effect among people who take Magnesium (magnesium), especially for people who are female, 40-49 old, also take Celebrex, and have Pain.

The phase IV clinical study analyzes which people have Restrictive pulmonary disease when taking Magnesium. It is created by eHealthMe based on reports of 117,376 people who have side effects when taking Magnesium from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,144 Magnesium users. Check the latest studies of Magnesium.

What is Restrictive pulmonary disease?

Restrictive pulmonary disease (reduction in total lung capacity) is found to be associated with 307 drugs and 362 conditions by eHealthMe. Check the latest studies of Restrictive pulmonary disease.

On Jul, 10, 2026

117,376 people reported to have side effects when taking Magnesium.
Among them, 17 people (0.01%) have Restrictive pulmonary disease.

Could Magnesium cause Restrictive pulmonary disease?

Among these 17 people:

What is the gender of people who have Restrictive pulmonary disease when taking Magnesium? *

female: 94.12 %
male: 5.88 %

What is the age of people who have Restrictive pulmonary disease when taking Magnesium? *

What are other drugs people take besides Magnesium? *

Celebrex: 13 people, 76.47%
Anafranil: 12 people, 70.59%
Pantoprazole: 11 people, 64.71%
Diclofenac: 11 people, 64.71%
Duspatal: 5 people, 29.41%
Aspirin: 3 people, 17.65%
Vitamin D: 2 people, 11.76%
Diazepam: 2 people, 11.76%
Tramadol Hydrochloride: 2 people, 11.76%
Ibuprofen: 2 people, 11.76%

What are other side effects people have besides Restrictive pulmonary disease? *

Pain: 13 people, 76.47%
Dyspnea Exertional: 13 people, 76.47%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 13 people, 76.47%
Nasal Septum Deviation (deviated nasal septum): 13 people, 76.47%
Fatigue (feeling of tiredness): 13 people, 76.47%
Fibromyalgia (a long-term condition which causes pain all over the body): 13 people, 76.47%
Flatulence (flatus expelled through the anus): 13 people, 76.47%
Depression: 13 people, 76.47%
Malaise (a feeling of general discomfort or uneasiness): 13 people, 76.47%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 13 people, 76.47%

What are the existing conditions these people have? *

Pain: 13 people, 76.47%
Fibromyalgia (a long-term condition which causes pain all over the body): 12 people, 70.59%
Myosclerosis (hardening of muscle tissue): 11 people, 64.71%
Joint Pain: 2 people, 11.76%
Stress And Anxiety: 1 person, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Rashes (redness): 1 person, 5.88%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.88%
Oedema Peripheral (superficial swelling): 1 person, 5.88%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and have Restrictive pulmonary disease?

- Check whether Restrictive pulmonary disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Magnesium:

Magnesium (121,144 reports)

Browse all side effects of Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (307 drugs)

Browse all the conditions that are associated with Restrictive pulmonary disease:

Restrictive pulmonary disease (362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on magnesium (the active ingredients of Magnesium) and Magnesium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.